White House Tells States to Prepare for COVID Vaccinations in Young Children

In anticipation of the FDA green light, the administration has begun planning for the vaccination effort with states, pharmacies and medical groups

Oct. 13, 2021

By Shannon Pettypiece

The White House told governors to start preparing to vaccinate children as young as age 5 by early November in anticipation of the FDA clearing Pfizer's COVID vaccine for that age group in the coming weeks, a White House official said.

The Biden administration has purchased 65 million pediatric doses of the Pfizer vaccine, enough to vaccinate the estimated 28 million children who would be eligible should the FDA approve Pfizer’s request to vaccinate kids ages 5 to 11, according to a Health and Human Services official.

Pfizer and BioNTech said earlier this month that they had submitted an emergency request for authorization for those ages 5 to 1, and an FDA advisory committee plans to meet to discuss the request on Oct. 26. The vaccine doses for the youngest age group won’t be interchangeable with those used in adults because it has a different dosage and dilution requirement.

In anticipation of the FDA green light, the administration has begun planning for the vaccination effort with states, pharmacies and medical groups. The administration told providers in a planning document last week that the vaccine for children will be delivered to thousands of sites within a week of FDA authorization.

The Centers for Disease Control and Prevention has been working to enroll providers in the Covid vaccination program, and HHS is planning a messaging and outreach campaign to encourage parents to get their children vaccinated, the HHS official said.

Vaccinations among children 12 and older have lagged those of adults, with just 55 percent of 12- to 15-year-olds having been at least partly vaccinated, along with 62 percent of 16- and 17-year-olds. That compares to more than 70 percent of adults over 40.